Skip to main navigation
Decibel Therapeutics logo
Menu Button

Top Menu

  • JOIN US
  • CONTACT US

Main Corporate Nav

  • About Us
  • The Need
  • Our Approach
  • Pipeline
  • Patients & Families
    • Genetic Testing
    • Patients and Families
    • Resources
  • Investors
    • Overview
    • News & Events
      • Press Releases
      • Events & Presentations
    • Stock Information
      • Stock Quote & Chart
      • Historical Price Lookup
      • Analyst Coverage
    • Financials
      • SEC Filings
    • Governance
      • Documents & Charters
      • Board of Directors
      • Leadership
      • Committee Composition
    • IR Resources
      • Email Alerts
      • Investor Contact
      • Investor FAQs
  • Join Us
  • Contact Us

SEC Filings

Filing date Form Description View
April 6, 2023 8-K

Report of unscheduled material events or corporate event

0000950170-23-012063.pdf
0000950170-23-012063.rtf
0000950170-23-012063.xls
EX-101.PRE - XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT View HTML
April 14, 2023 PRE 14A

A preliminary proxy statement providing notification matters to be brought to a vote

0000950170-23-012800.pdf
0000950170-23-012800.rtf
0000950170-23-012800.xls
View HTML
April 28, 2023 DEF 14A

Official notification to shareholders of matters to be brought to a vote ("Proxy")

0000950170-23-015486.pdf
0000950170-23-015486.rtf
0000950170-23-015486.xls
View HTML
April 28, 2023 DEFA14A

Additional proxy soliciting materials - definitive

0000950170-23-015491.pdf
0000950170-23-015491.rtf
View HTML
April 28, 2023 ARS

An annual report to security holders

0000950170-23-015495.pdf
0000950170-23-015495.rtf
View HTML
May 15, 2023 10-Q

Quarterly report which provides a continuing view of a company's financial position

0000950170-23-021967.pdf
0000950170-23-021967.rtf
0000950170-23-021967.xls
EX-101.DEF - XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT View HTML
June 13, 2023 8-K

Report of unscheduled material events or corporate event

0000950170-23-027704.pdf
0000950170-23-027704.rtf
0000950170-23-027704.xls
EX-101.LAB - XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT View HTML
June 14, 2023 4

Statement of changes in beneficial ownership of securities

0000950170-23-027990.pdf
0000950170-23-027990.rtf
0000950170-23-027990.xls
View HTML
June 14, 2023 4

Statement of changes in beneficial ownership of securities

0000950170-23-027992.pdf
0000950170-23-027992.rtf
0000950170-23-027992.xls
View HTML
June 14, 2023 4

Statement of changes in beneficial ownership of securities

0000950170-23-027996.pdf
0000950170-23-027996.rtf
0000950170-23-027996.xls
View HTML

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 10
  • Page 11
  • Page 12
  • Page 13
  • Current page 14
  • Page 15
  • Page 16
  • Page 17
  • Page 18
  • Next page Next ›
  • Last page Last »
Displaying 131 - 140 of 172 results

Data provided by Kaleidoscope.

Shareholder Tools

Contact IR
Contact IR
Email Alerts
Email Alerts
Print Page
Print Page
RSS Feeds
RSS Feeds
Search
Search

© Decibel Therapeutics, Inc. 2023. All rights reserved.

  • Privacy Notice
  • Terms of Use
  • Twitter
  • LinkedIn

Main Corporate Nav

  • About Us
  • The Need
  • Our Approach
  • Pipeline
  • Patients & Families
    • Genetic Testing
    • Patients and Families
    • Resources
  • Investors
    • Overview
    • News & Events
      • Press Releases
      • Events & Presentations
    • Stock Information
      • Stock Quote & Chart
      • Historical Price Lookup
      • Analyst Coverage
    • Financials
      • SEC Filings
    • Governance
      • Documents & Charters
      • Board of Directors
      • Leadership
      • Committee Composition
    • IR Resources
      • Email Alerts
      • Investor Contact
      • Investor FAQs
  • Join Us
  • Contact Us